Antibodies against co-stimulatory molecules, such as 4-1BB (CD137) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4, CD152) have the potential to enhance immune responses and produce anti-tumor immunity [7]–[10]. The gene discussed is CTLA4; the disease is neoplasm.